IRIS Accounts Production v25.2.0.378 13031301 director 1.12.23 30.11.24 30.11.24 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh130313012023-11-30130313012024-11-30130313012023-12-012024-11-30130313012022-11-30130313012022-12-012023-11-30130313012023-11-3013031301ns15:EnglandWales2023-12-012024-11-3013031301ns14:PoundSterling2023-12-012024-11-3013031301ns10:Director12023-12-012024-11-3013031301ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3013031301ns10:SmallEntities2023-12-012024-11-3013031301ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-3013031301ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-3013031301ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-3013031301ns10:FullAccounts2023-12-012024-11-3013031301ns10:RegisteredOffice2023-12-012024-11-3013031301ns5:CurrentFinancialInstruments2024-11-3013031301ns5:CurrentFinancialInstruments2023-11-3013031301ns5:ShareCapital2024-11-3013031301ns5:ShareCapital2023-11-3013031301ns5:RetainedEarningsAccumulatedLosses2024-11-3013031301ns5:RetainedEarningsAccumulatedLosses2023-11-3013031301ns5:PlantMachinery2023-12-012024-11-3013031301ns5:PlantMachinery2023-11-3013031301ns5:PlantMachinery2024-11-3013031301ns5:PlantMachinery2023-11-30
REGISTERED NUMBER: 13031301 (England and Wales)















Unaudited Financial Statements for the Year Ended 30 November 2024

for

The Ophthalmic Group Ltd

The Ophthalmic Group Ltd (Registered number: 13031301)






Contents of the Financial Statements
for the Year Ended 30 November 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


The Ophthalmic Group Ltd

Company Information
for the Year Ended 30 November 2024







DIRECTOR: Dr A Burke





REGISTERED OFFICE: 59 Trinity Road
Wirral
Cheshire
CH47 2BS





REGISTERED NUMBER: 13031301 (England and Wales)





ACCOUNTANTS: Francis & Co
Second Floor
123 Promenade
Cheltenham
Gloucestershire
GL50 1NW

The Ophthalmic Group Ltd (Registered number: 13031301)

Balance Sheet
30 November 2024

30.11.24 30.11.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 267 534

CURRENT ASSETS
Cash at bank 39,524 38,398

CREDITORS
Amounts falling due within one year 5 36,283 34,400
NET CURRENT ASSETS 3,241 3,998
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,508

4,532

CAPITAL AND RESERVES
Called up share capital 24 24
Retained earnings 3,484 4,508
3,508 4,532

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 26 February 2025 and were signed by:





Dr A Burke - Director


The Ophthalmic Group Ltd (Registered number: 13031301)

Notes to the Financial Statements
for the Year Ended 30 November 2024

1. STATUTORY INFORMATION

The Ophthalmic Group Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 December 2023
and 30 November 2024 801
DEPRECIATION
At 1 December 2023 267
Charge for year 267
At 30 November 2024 534
NET BOOK VALUE
At 30 November 2024 267
At 30 November 2023 534

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Taxation and social security 1,943 466
Other creditors 34,340 33,934
36,283 34,400